Comprehensive Management of Aging in HIV

Barcelona (Spain)


27-28th September 2018

The 3rd edition of the International workshop on Comprehensive management of Aging in HIV was held on the 27th and 28thof September 2018 in Barcelona

The meeting was a great success with a hundred attendees from over 18 countries!

The Scientific and Organizing Committee we would like to thank all invited speakers, chairs and attendees for their valuable contributions.

We would like to express our gratitude to our supporters ViiV Healthcare and Merck Sharp & Dohme, Corp for making this event possible.

We look forward to the next edition of the workshop that will be held in Buenos Aires, Argentina in 2019

If you want to be updated on the upcoming events please subscribe to 

Currently in high-income countries, 50% of HIV-infected subjects are over 50 years of age and the proportion of infected people older than 65 years grew 10-fold in the last years.

Aging is associated with the decline and deterioration of functional properties at the cellular, tissue and organ level that yields a loss of homeostasis and decreased adaptability to internal and external stress. All these changes increase the vulnerability to disease and mortality. Atherosclerosis and cardiovascular events, loss of renal function, osteopenia/osteoporosis, and non–AIDS-defining cancers are some of the emerging conditions observed in large observational cohorts of HIV-infected subjects whose incidence seems to be higher than in the general population. The increased life expectancy of this population together with the HIV-related chronic inflammation and the long exposure to some antiretroviral drugs are the main reasons of the accelerated aging in these patients.

Healthcare professionals agree that a special management of aging people reduces morbidities and mortality, as well as improves quality of life and conserves the ability to carry out the activities of daily living. In addition, an individualized and carefully choice of the antiretroviral combination should be considered in this population due to the polypharmacy and the drug-drug interactions, common in among these patients.

The objective of the workshop is to review the hottest topics on HIV infection and aging from a multidisciplinary point of view, as well as to provide an up to date overview of other issues such as the emergence of resistance mutations to the new antiretroviral drugs or the management of the HIV/HCV coinfection in the aging HIV-infected population.

This workshop is therefore aimed not only to healthcare professionals but also to researchers, representatives from educational institutions and academia, as well as, pharmaceutical industries.

Scientific Committee

Fundación Huesped and Buenos Aires University Medical School, Argentina
Fundación Huésped y Facultad de Medicina, Universidad de Buenos Aires, Argentina
University College London
Fight AIDS and Infectious Diseases Foundation, Irsicaixa, and Hospital Universitari Germans Trias i Pujol, Spain
Fundació Lluita contra la Sida i les Malalties Infeccioses, Irsicaixa, y Hospital Universitari Germans Trias i Pujol, Spain
University of Modena and Reggio Emilia. Italy
Fundación Huésped, Buenos Aires Argentina
University College Dublin. School of Medicine and Medical Science, Ireland.
Fight AIDS and Infectious Diseases Foundation, Hospital Universitari Germans Trias i Pujol, Spain
Fundació Lluita contra la Sida i les Malalties Infeccioses, Hospital Universitari Germans Trias i Pujol, Spain
UCD School of Medicine, St Vincent's University Hospital
Director of clinical research, Fundación Huésped
Fundación Huésped, Buenos Aires, Argentina
Université de Montréal. Canada
Directora Científica, Fundación Huésped, Argentina
Director of clinical research, Fundación Huésped, Argentina

The Comprehensive Management of Aging in HIV-Infected Subjects (Barcelona, Spain) has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 8 European CME credits (ECMEC®s).